Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Early Discovery, Family Understanding Important to Treat OCD: GSK Seminar
February 20, 2006
- BUSINESS NEWS IN BRIEF
February 20, 2006
- JASDI Forum on Drug Information Needed by Patients
February 20, 2006
- 188th PMAT Seminar
February 20, 2006
- MEDICAL DEVICE NEWS IN BRIEF
February 20, 2006
- Present New Invoice Prices within 3 Days after New NHI Price Announcement: FJPWA
February 20, 2006
- HIV Drug Resistance Measurement Method Developed
February 20, 2006
- Managerial-level Workers at Pfizer Japan Form New Labor Union
February 20, 2006
- Fuji Biomedix Develops Kit to Diagnose Malignancy of Colon Cancer
February 20, 2006
- Aiming at \10 Bil. Sales with Seibule: Sanwa Kagaku
February 20, 2006
- ＜OPINION＞ Romancing the Right Remuneration
February 20, 2006
- R&D NEWS IN BRIEF
February 20, 2006
- Dr M. Angell's Book Publication Seminar
February 20, 2006
- Univ. Hospitals Should Improve Infrastructure for TR: Prof. Fukushima
February 20, 2006
- APDD to Promote Clinical Trials
February 20, 2006
- ＜Symposium＞ "Tamiflu Should Not Be Used": Medwatcher Japan
February 20, 2006
- REGULATORY NEWS IN BRIEF
February 20, 2006
- Chuikyo's Reform to Take Place in March 2007
February 20, 2006
- Bill Payers, Care Providers Clash on Mandatory Receipts
February 20, 2006
- Chugai to Start Big Leap Forward in 2006
February 20, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…